Now I have all the information needed to write the final review. Let me synthesize everything.

---

## Summary

This paper introduces *Constrained Mass Transport* (CMT), a variational framework for sampling from unnormalized Boltzmann distributions (Boltzmann generators) by constructing an annealing path of intermediate densities under two simultaneous constraints: a trust-region constraint bounding the KL divergence between successive densities, and an entropy constraint controlling the rate of entropy decay. The authors derive closed-form optimal intermediate densities under each constraint (Propositions 2.1–2.3) and connect these to generalized annealing paths (Theorem 2.4). Empirically, CMT consistently outperforms state-of-the-art annealing-based and variational baselines (FAB, TA-BG) on four molecular systems of increasing dimensionality (up to d=219), achieving roughly 2× higher effective sample size on the largest systems while avoiding mode collapse. A new benchmark, the ELIL tetrapeptide (d=219), is also introduced.

## Strengths

1. **Principled theoretical framework with closed-form solutions.** Propositions 2.1–2.3 derive analytical forms for the optimal intermediate densities under each constraint scheme (trust-region, entropy, and hybrid). Theorem 2.4 shows these yield generalized annealing paths (geometric, tempered, geometric-tempered) that interpolate between prior and target while keeping KL divergence and entropy change bounded. The Lagrangian dual formulation (Eq. 11, 16) is efficient — the authors report 0.01% overhead on alanine dipeptide.

2. **Consistent and substantial improvements across challenging molecular systems.** Table 1 shows CMT achieves the best EUBO and highest ESS on all four systems. The margin grows with system complexity: on alanine hexapeptide (d=180), CMT achieves 29.63% ESS vs. 18.22% for the best baseline (TA-BG); on the newly introduced ELIL tetrapeptide (d=219), CMT achieves 26.06% ESS vs. 13.75% for TA-BG — roughly a 1.9× improvement. These gains hold while using the same or fewer target evaluations than competing methods.

3. **Introduction of a meaningful new benchmark.** The ELIL tetrapeptide (d=219) with more complex side-chain interactions than existing alanine-based benchmarks is a genuine contribution to the community. The paper convincingly demonstrates that CMT scales to this larger system where baselines struggle (e.g., reverse KL achieves only 1.26% ESS).

4. **Strong reproducibility commitment.** Code and ground-truth MD data are publicly released. All methods use identical normalizing flow architectures, and the experimental setup (target evaluations, annealing steps, architectures) is clearly specified.

## Weaknesses

### Fatal
None.

### Major
None.

### Minor

1. **Inconsistent ablation presentation (Figure 3 caption vs. main text).** The main text (Section 5.2) accurately states: "Visible signs of mode collapse appear in all cases except for the tempered (7) and geometric-tempered (9) variants." This means the entropy-only (tempered) variant avoids mode collapse. However, the figure caption states: "Using a single or no constraint leads to mode collapse, whereas combining both constraints avoids it." These statements contradict each other regarding whether a single constraint (tempered/entropy-only) suffices. The actual data in Figure 2d shows a more nuanced picture: tempered (entropy-only) avoids mode collapse on Ramachandran plots but has the lowest ESS to target (15.11%), while geometric (trust-region-only) has the highest ESS (33.42%) but exhibits mode collapse — meaning both are needed for the best combination of mode coverage *and* sampling efficiency. The caption's overstatement is misleading and should be corrected to align with the more nuanced text.

2. **One case where CMT is not best is left unremarked.** On the ELIL tetrapeptide, TA-BG achieves a better RAM TV (2.54×10⁻²) than CMT (3.13×10⁻²), yet this is not discussed. The paper's summary statement that CMT "provides superior mode coverage... (RAM TV)" across all systems is slightly overbroad. While CMT dominates on EUBO and ESS, this exception deserves at least a brief comment.

3. **Theoretical-practical gap is acknowledged but not examined.** The paper derives optimal densities assuming optimization over all probability measures (Propositions 2.1–2.3), then approximates them with normalizing flows via importance-weighted forward KL. The paper correctly notes this approximation gap but does not empirically verify whether the constraints (KL and entropy bounds) remain approximately satisfied after flow approximation. This is a common limitation in variational methods and does not invalidate the results, but addressing it (e.g., by checking constraint satisfaction on the approximated densities) would strengthen the paper's claim of providing a *principled* framework.

### Trivial

- The figure caption for Figure 3 is misaligned with the main text, as described above. This is a copy-editing issue that needs correction.

## Nice-to-Haves

- A sensitivity analysis of ε_tr and ε_ent (the trust-region and entropy bounds) on at least one system would help practitioners understand how to set these hyperparameters on new problems.
- An empirical check of whether the actual KL divergence and entropy change between *approximated* consecutive densities remain bounded by the prescribed ε_tr and ε_ent would directly connect the theory to the practice.
- The text "Geometric-tempered" in Figure 2d's ESS-to-target values (33.42% for geometric-only vs. 29.63% for geometric-tempered) shows geometric-only has higher ESS despite mode collapse — the paper already marks collapsed variants with a star ★, which is the right approach, but a brief explanation of why ESS can be misleading in the presence of mode collapse would be helpful for readers.

## Removed Points

These points are flagged to be removed; treat them with caution.

- *"Comparison fairness across methods"* (harsh critic's issue #3 about differing target eval counts): The paper controls for architecture and reports target eval counts. The asymmetry (more target evals for baselines) favors baselines, not CMT. The reviewer acknowledges this is defensible. Drops to a non-issue.
- *"Gap between analytical solution and practical approximation"* (harsh critic's issue #2): The paper explicitly acknowledges this in Section 3. It is a standard limitation of all variational methods that parametrize over a restricted family. Kept as a minor weakness above, not a critical issue.
- *"Missing related works"*: Removed per instructions. The paper provides a comprehensive related work section (Section 4).
- *Strength Finder's claim that the ablation "demonstrates that both constraints are necessary"*: The data does demonstrate this (neither alone achieves the best balance), but the presentation inconsistency makes the narrative muddled. The weakness above captures this.
- *Strength Finder's generic strengths* ("this paper addressed an important problem") removed.

## Novel Insights

None beyond the paper's own contributions.

## Suggestions

1. Correct the Figure 3 caption to match the main text. If the intended claim is "the trust-region constraint alone leads to mode collapse despite high ESS; the entropy constraint alone avoids mode collapse but yields low ESS; both together give the best balance" — state this clearly and consistently.
2. Add a brief sentence in Section 5.2 acknowledging the ELIL tetrapeptide RAM TV result where TA-BG leads, and offer a possible explanation (e.g., different metric sensitivity, larger variance).
3. Consider adding a simple empirical check of constraint satisfaction (actual KL and entropy changes between approximate flow densities) to close the theory–practice loop.

## Score and Decision

### Calibration Report

**Round 1 — Bracketing.** Three queries on "Boltzmann generator normalizing flow molecular sampling constrained optimization":

- **Weak band (score < 3.5):** kKXIYUi8ff (3.00, Reject), ItPYVON0mI (3.00, Reject), OcTUquFXfx (2.60, Reject), H380m98pLE (2.50, Reject). All are on tangentially related molecular simulation topics with weak contributions. CMT is clearly far above these.

- **Middle band (3.5 < score < 7.5):** pRCOZllZdT — BoPITO (7.00, Accept, scores 6,6,8,8); TUvg5uwdeG — Fisher-Rao Curves (6.40, Accept, scores 8,5,8,5,6); D2EdWRWEQo — FreeFlow (5.50, Reject, scores 5,6,3,8); ybWOYIuFl6 — BNEM (6.00, Reject, scores 8,8,3,5).

- **Strong band (score > 7.5):** NSVtmmzeRB — GeoBFN (8.00, Accept); ZCOwwRAaEl — NF-BO (8.00, Accept); kJFIH23XhB — FoldFlow (8.00, Accept); gHLWTzKiZV — Unbalanced FM (8.00, Accept). These are top-tier generative modeling papers on related but distinct topics (molecule generation, protein design). CMT is clearly below these in scope and maturity.

**Initial bracket:** score 5.5–7.0 was the plausible range.

**Round 2 — Narrowing.** Two queries in the (4.5, 6.5) and (6.0, 7.5) ranges retrieved overlapping anchors already read (Fisher-Rao 6.40, BoPITO 7.00, BNEM 6.00) plus new ones: Jj4XIKX4TJ — SO(3) flow matching (6.00, Reject, scores 5,5,6,8,6); GK5ni7tIHp — TFG-Flow (6.25, Accept); CkozFajtKq — LiFlow (6.33, Reject, scores 8,3,8,8,5,6); 84WmbzikPP — Stiefel Flow (7.00, Accept).

**Comparison to anchors:**
- vs. BNEM (6.00, Reject): CMT is clearly stronger — BNEM was criticized for incremental novelty and limiting to toy systems (2D GMM, LJ clusters). CMT tackles real molecular systems up to d=219 with a clearer theoretical contribution.
- vs. FreeFlow (5.50, Reject): CMT is stronger — FreeFlow was criticized for lacking baselines and experimental rigor.
- vs. LiFlow (6.33, Reject): CMT is comparable or slightly stronger — LiFlow had mixed reviews (scores 8,3,8,8,5,6) with novelty concerns.
- vs. Fisher-Rao Curves (6.40, Accept): CMT has far stronger empirical validation (real molecular systems vs. 2D toy examples). Fisher-Rao has deeper theory but limited practical demonstration.
- vs. BoPITO (7.00, Accept): CMT evaluates on larger systems and doesn't require a pre-trained component, but has the ablation presentation issue. Slightly below BoPITO's overall polish.

**Final score:** 6.5

MY FINAL SCORE: <score>6.5</score>
MY FINAL DECISION: <decision>Accept</decision>